← FDA Drug Approvals (Drugs@FDA)

KYRA

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM · Approved 2019-07-23

Drug application

FDA Application #

ANDA202318

Application type

Abbreviated New Drug Application (Generic)

Brand name

KYRA

Generic name

Drospirenone

Active ingredients

DROSPIRENONE; ETHINYL ESTRADIOL

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

SUN PHARM

First approval

2019-07-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown